Skip to main content

Table 4 Essential amino acid fractions in different groups of bladder cancer and bilharzial bladder cancer patients

From: Levels of certain tumor markers as differential factors between bilharzial and non-biharzial bladder cancer among Egyptian patients

Parameters

Control

Bladder cancer

Bilharzial bladder cancer

% Change

    

(a)

(b)

(c)

Isoleucine

2.75 ± 0.390

5.27 ± 1.24

5.3 ± 0.89

+92

+52

+90

Leucine

5.36 ± 0.397

9.73 ± 2.88

9.99 ± 1.82

+81

+29

+86

Threonine

7.70 ± 1.175

9.78 ± 3.30

8.3 ± 2.63

+27

-37

+8

Valine

3.15 ± 0.83

10.28 ± 4.43

11.6 ± 2.32

+226

+51

+267

Phenylalanine

3.12 ± 0.46

5.07 ± 1.07

4.7 ± 0.78

+62

+31

+51

1-Methyl-Histidine

5.22 ± 0.58

7.48 ± 1.167

6.7 ± 2.27

+43

+36

+29

Lysine

8.56 ± 1.43

16.59 ± 3.98

16.9 ± 3.22

+94

+75

+97

Trytophan

1.34 ± 0.39

0.000 ± 0.00

1.5 ± 1.35

-100

-66

+15

Carnosine

2.84 ± 0.58

1.18 ± 0.62

2.1 ± 0.71

-58

-41

-26

Cystathionine

0.923 +0.59

0.153+0.14

0.47 +0.99

-83

-84

-49

  1. • Data are means ± S.D. of five patients in each group.
  2. • Total amino acid is expressed as g/L serum.
  3. • (a, b and c) percentage change as compared with control.